We are taking on infectious diseases with the hope of creating a better world.
Our decades of research in infectious diseases have led to profound scientific advances
We’ve been combating global health threats caused by infectious diseases for more than a century. From developing one of the first antibiotics to pioneering research in HIV science, our focus has always been on the prevention and treatment of diseases that threaten people and communities around the world. But our work is far from done.
Every year, millions of people die from infectious diseases. The world is counting on us to bring forward new approaches to help ease human suffering.
Our work in infectious diseases
years committed to research to help combat the challenges of the HIV epidemic
the year we began producing penicillin "G"
investigator-initiated antimicrobial stewardship programs funded across the globe
Our legacy in innovative HIV science continues
We remember when HIV was one of society's most daunting challenges, when millions of people lost their lives to the devastating AIDS epidemic. Our scientists embarked on an urgent mission to unravel and understand the virus, which led to groundbreaking research in HIV.
We are still driven to do more. We are pushing the boundaries of HIV science because unmet medical need still endures. Eradication of the virus is our ultimate goal.
Continuing research and striving for improvements in the use of antibiotics
While other companies pull away from antibiotic research and development, we stand out from the pack. We continue our efforts, because we know the world needs it.
Joining a partnership to combat a deadly virus
Since the emergence of the Ebola virus in 1976, periodic outbreaks have been a global health challenge. We are proud to be part of the global public-private partnership that has united government, industry, community groups, scientists, health care workers and ordinary people, to come together to help fight this deadly disease.
Programs that can make a difference
We are leading programs that reach patients where they already are
To help address disparities in HIV care, our Foundation established HIV Care Connect. The multi-site initiative aims to reduce disparities in access to HIV care and help improve health outcomes for people living with HIV in the Southeastern U.S. who are disproportionately affected.
The people and programs that are helping to combat infectious diseases
Explore the ways we are focusing our efforts on research in infectious disease.
Moving quickly to help support efforts to address the Ebola outbreak in Uganda
See how our people are planning to produce investigational vaccine for an urgent global health need
Antimicrobial resistance – an emerging public health crisis
Q&A with Dr. Jenelle Krishnamoorthy on the urgent need to work together to address the threat of antimicrobial resistance (AMR)
Our commitment to patients is unwavering
As long as there are still patients in hospitals, doctors desperate to add years to the lives of their patients, and a world where treatments aren’t accessible to all, we will be here: fighting with all we have to deliver more, sooner.